Lars Berglund, M.D., Ph.D.

Lars F. Berglund, M.D., Ph.D.

Specialties

Endocrinology, Diabetes, and Metabolism

Title

  • Associate Vice Chancellor for Biomedical Research, UC Davis
  • Vice Dean for Research, UC Davis School of Medicine
  • Emeritus Director, UC Davis Clinical and Translational Science Center
  • Professor of Medicine

Reviews

Clinical and Translational Science Center

2921 Stockton Blvd., Suite 1400
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-703-9184

Additional Phone Numbers

Phone: 916-800--4-UCDAVIS (800-482-3284)
Phone: 916-703-9120

WEBSITES

Specialty:
www.ucdmc.ucdavis.edu/ctsc

Research/Academic Interests

Dr. Berglund oversees all aspects of the School of Medicine research portfolio, with responsibility for strategic planning, space assignments, matching and bridging funds, and representing the school at the institutional and national level. He works closely with center directors and department chairs in strategic recruitments and development of research initiatives.

Berglund also is emeritus director of the Clinical and Translational Science Center (CTSC), and was responsible for all of the center’s infrastructure activities, including services, education and translational science projects. He serves as principal investigator for the health system’s KL2 and TL1 training grant programs, which accelerate the career development of promising junior faculty and pre-doctoral students. Through these activities, he has mentored a wide range of trainees, including undergraduate and graduate students, fellows and junior faculty.

Berglund also serves as one of three principal investigators for the UC Davis FUTURE program, which is funded by a NIH Director’s BEST award to develop novel career pathways for graduate students. He has participated in Clinical and Translational Science Award network activities and served as the inaugural co-chair of the CTSA Steering committee. 

Berglund is a member of the editorial boards of several journals. He has chaired a NIH study section and a national American Heart Association study section, and has served on multiple NIH study sections and on committees for the American Heart Association, the Endocrine Society and a National Academies Steering Committee for the Decadal Survey on Biological and Physical Sciences in Space.

Center/Program Affiliation

Clinical and Translational Science Center

Education

M.D., University of Uppsala, Uppsala, Sweden, 1981

Ph.D., University of Uppsala, Uppsala, Sweden, 1977

Internship: Huddinge University Hospital, Stockholm, Sweden 1981-1982

Residency

Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden 1982-1984

Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden 1984-1986

Fellowships

UC San Diego, San Diego CA 1977-1979

Professional Memberships

American Association for the Advancement of Science

American Association of Clinical Chemistry

American Heart Association, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Endocrine Society

European Society of Clinical Investigation

Swedish Society of Clinical Chemistry

Select Recent Publications

Anuurad E, Byambaa E, Gungor Z, Zhang W, Pearson TA, Tracy RP, Kim K, Berglund L. Age as a modulator of inflammatory cardiovascular risk factors. Arteriosclerosis, Thrombosis and Vascular Biology (2011), 31:2151-2156.

Enkhmaa B, Anuurad E, Ozturk Z, Zhang W, Pearson TA, Berglund L. Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Translational Research (2011), 158:92-98.

Stanhope KL, Griffen SC, Bremer AA, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Hellerstein MK, Berglund L, Keim NL, Havel PJ. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-hour glucose and insulin excursions. American Journal of Clinical Nutrition (2011), 94:112-119.

Enkhmaa B, Anuurad E, Pearson TA, Zhang W, Berglund L. Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population. Atherosclerosis (2010), 211: 526-530.

Enkhmaa B, Anuurad E, Zhang Z, Pearson TA, Berglund L. Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. American Journal of Cardiology (2010), 106: 1264-1269.

Kasim-Karakas S, Hyson D, Halsted C, van Loan M, Chedin E, Berglund L. Translational nutrition research at UC Davis ? The key role of the Clinical and Translational Science Center. Annals of the New York Academy of Science (2010), 1190; 179-183.

Ozturk Z, Enkhmaa B, Shachter NS, Berglund L, Anuurad E. Integrated role of two apoliprotein e polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population. Metabolic Syndrome and Related Disorders (2010), 8: 531-538.

Reis SE, Berglund L, Bernard GR, Califf RM, FitzGerald GA, Johnson PC for the National CTSA consortium. A Roadmap for Re-engineering the National Clinical and Translational Research Enterprise: The National Clinical and Translational Science Award (CTSA) Consortium?s Strategic Plan. Academic Medicine (2010), 85: 463-469.

Anuurad E, Ozturk Z, Enkhmaa B, Pearson TA, Berglund L. Association of Lp-PLA2 with coronary artery disease: increased role of vascular inflammation in African Americans compared to Caucasians. Journal of Clinical Endocrinology and Metabolism (2010), 95: 2376-2383.

Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L. Increased stroke risk and lipoprotein(a) in a multi-ethnic community: The Northern Manhattan Stroke Study. Cerebrovascular Disease (2010), 30: 237-243.

Califf RM, Berglund L for the Principal Investigators of the National Institute of Health Clinical and Translational Science Awards. Linking Scientific Discovery and Better Health for the Nation: The Maturation of Clinical and Translational Research in the United States. Academic Medicine (2010), 85: 457-462.